Abstract:Approximately 24 000 infants are born to women with epilepsy each year in the USA.1 The current recommendation for epileptic women during pregnancy is continuation of antiepileptic therapy to avoid seizures that can be dangerous for the fetus and the mother. The specific anticonvulsant drugs used by pregnant women have changed over time. Valproate, phenytoin, carbamazepine, and phenobarbital were the most commonly used drugs until the 1990s. During the past 10 years, a second generation of anticonvulsants has taken over.2 Some of these new anticonvulsants (e.g., topiramate) are also used as mood stabilizers and to prevent migraine headaches. All traditional anticonvulsants have been associated with an increased risk of congenital malformations, although the magnitude of the risks and the specific abnormalities vary by drug. In a recent study, the prevalence of major malformations at birth in infants exposed early in pregnancy ranged between 9.3% for valproate to 2.0% for lamotrigine.3 Besides valproate,4 primidone, phenobarbital, phenytoin, and carbamazepine have also been associated with oral clefts, among other defects.5,6 Less is known about the safety of newer anticonvulsants during pregnancy. For topiramate, two pregnancy registries from the UK and North America reported a risk of oral clefts of 29 per 1000 (95%CI 5 to 91)7 and 14 per 1000 (95%CI 5 to 31),3 respectively, after first trimester exposure; over 10 times the background risk in those populations. One cohort study from Denmark reported a risk of 9.3 cases per 1000 (95%CI 0.5 to 45) compared with 1.7 per 1000 in their unexposed population.8 An increased risk of cleft lip was also identified in infants ascertained in two large case–control studies: The National Birth Defects Prevention Study and the Slone Epidemiology Center Birth Defects Study, which estimated a pooled odds ratio of 5.4 (95% CI 1.5 to 20.1).9 The small number of exposed cases in each of these individual studies reflects a major challenge when evaluating the safety of anticonvulsants during pregnancy. Because teratogens often increase the risk of specific defects, and not malformations overall, it is important to consider specific defects. Yet, specific defects such as oral clefts occur in as few as 1 per 1000 live births. Moreover, because different anticonvulsants may carry different teratogenic effects, it is critical to consider specific drugs. Obtaining enough exposed pregnancies to study the risk of specific defects requires very large sample sizes. However, large data sources typically lack detailed information on potential confounders (e.g., smoking) and are based on prescription or dispensing data rather than actual drug intake. In this issue of Pharmacoepidemiology and Drug Safety,10 Mines and colleagues present a large multidatabase cohort study with case validation that compared the prevalence of non-syndromic oral clefts at birth in infants of women exposed to topiramate in the first trimester with the prevalence in two different reference groups: (i) infants of women formerly exposed to any antiepileptic drug and (ii) infants of unexposed women matched on indication to those exposed to topiramate. The prevalence of oral clefts was 3.6 per 1000 in the topiramate-exposed group, 1.4 in the past users group, and 0.7 in the unexposed group. The prevalence ratios standardized by site were 2.5 (95% CI: 1.0–6.0) and 5.4 (95% CI: 2.0–14.6), respectively. *Correspondence to: S. Hernandez-Diaz, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA. E-mail: shernan@hsph.harvard.edu

What are the reasons for a longer operation time in robotic gastrectomy than in laparoscopic gastrectomy for stomach cancer?

Robotic versus laparoscopic Gastrectomy for gastric cancer: a systematic review and updated meta-analysis

Short-term Outcomes of Laparoscopic Total Gastrectomy for Gastric Cancer: a Comparative Study with Laparoscopic Distal Gastrectomy at a High-Volume Center

Total laparoscopic versus robot-assisted laparoscopic pancreaticoduodenectomy.

Robotic versus laparoscopic gastrectomy for gastric cancer: comparison of short-term surgical outcomes

Comparison of robotic versus laparoscopic total gastrectomy for gastric cancer: a single-center retrospective cohort study in a Japanese high-volume center

Perioperative outcomes of robot-assisted versus laparoscopic distal gastrectomy for gastric cancer: a systematic review and meta-analysis of propensity score matching studies

The impact of robotic technology on the learning curve for robot-assisted gastrectomy in the initial clinical application stage

Comparison of short-term surgical outcomes between totally laparoscopic and laparoscopic-assisted distal gastrectomy for gastric cancer: a 10-y single-center experience with meta-analysis

Robotic Gastrectomy versus Laparoscopic Gastrectomy for Gastric Cancer

Surgical and short-term outcomes in robotic and laparoscopic distal gastrectomy for gastric cancer with enhanced recovery after surgery protocol: A propensity score matching analysis

Systematic review and meta-analysis of robotic surgery compared with conventional laparoscopic and open resections for gastric carcinoma

Short‐term outcomes of laparoscopic and robotic distal gastrectomy for gastric cancer: Real‐world evidence from a large‐scale inpatient database in Japan

Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer: A Systematic Review and Meta-Analysis

Intraoperative performance and outcomes of robotic and laparoscopic total gastrectomy for gastric cancer: A high‐volume center retrospective propensity score matching study

Robotic Versus Laparoscopic Distal Pancreatectomy: A Meta-Analysis Of Short-Term Outcomes

Cost analysis of robotic versus laparoscopic general surgery procedures

Evidence accumulates on the association between topiramate use early in pregnancy and the risk of oral clefts

Effects of the learning curve on operative time and lymph node harvesting during robotic gastrectomy

Retrospective analysis of operative time and time to discharge for laparoscopic vs robotic approaches to appendectomy and cholecystectomy

Case-matched Comparison of Laparoscopy-Assisted and Open Distal Gastrectomy for Gastric Cancer